IMRX – immuneering corporation - class a (US:NASDAQ)

News

Immuneering to Present at the Leerink Global Healthcare Conference [Yahoo! Finance]
Immuneering to Present at the Leerink Global Healthcare Conference
Immuneering Touts 64% 12-Month Survival for Atebimetinib in Pancreatic Cancer, Eyes Phase 3 [Yahoo! Finance]
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com